United States · FDA National Drug Code directory
topiramate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-004_69df5f84-1db1-4eb2-ae32-462137a4d812
- Product NDC
- 68382-004
- Form
- CAPSULE, COATED PELLETS
- Composition / generic term
- topiramate
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20091014
- Source listing expiry
- 20271231
Source-listed ingredients
- TOPIRAMATE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-004-01) · 68382-004-01
- 500 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-004-05) · 68382-004-05
- 1000 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-004-10) · 68382-004-10
- 60 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-004-14) · 68382-004-14
- 90 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-004-16) · 68382-004-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →